Hepatitis C recurrence after living donor and cadaveric liver transplantation;Recurrência da hepatite C após transplante hepático de doador vivo e falecido

Arquivos de Gastroenterologia

Volumn 46, Issue 1, 2009, Pages 38-42

  Coelho, Júlio Cezar Uili ^a,b   Okawa, Luciano ^a   Parolin, Mônica Beatriz ^b   De Freitas, Alexandre Coutinho Teixeira ^b   Fouto Matias, Jorge E ^b   Matioski, Alysson Rogério ^b  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b NONE

Author keywords

Hepatitis C; Liver transplantation; Living donors; Tissue donors

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; CADAVER; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LABORATORY TEST; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PROTHROMBIN TIME; RECURRENT DISEASE; TREATMENT INDICATION;

BRAZIL; CADAVER; FEMALE; GLUCOCORTICOIDS; GRAFT REJECTION; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; RECURRENCE;

EID: 66549112442     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032009000100012     Document Type: Article

References (29)

1. Bahra M, Neumann UP, Jacob D, Berg T, Neuhaus R, Langrehr JM, Neuhaus P. Outcome after liver re-transplantation in patients with recurrent chronic hepatitis C. Transpl Int. 2007;20:771-778 (Pubitemid 47221064)
2. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology, 1997;25:658-663 (Pubitemid 27106450)
3. Berenguer M. Management of hepatitis C virus in the transplant patient. Clin Liver Dis. 2007;11:355-376 (Pubitemid 46994759)
4. Berenguer M. Recurrent hepatitis C: worse outcomes established, interventions still inadequate. Liver Transpl. 2007;13:641-643 (Pubitemid 46796531)
5. Bittencourt PL, Silva RCSMA, Pessoa MG, Marroni CA. Resultado do inquérito nacional sobre condutas no acompanhamento e no tratamento da recurrência da hepatite C em portadores de vírus C submetidos a transplante de fígado. Arq Gastroenterol. 2007;44:78-84. (Pubitemid 47078908)
6. Coelho JCU, Parolin MB, Baretta GAP, Pimentel SK, Freitas ACT, Colman D. Qualidade de vida do doador após transplante hepático intervivos. Arq Gastroenterol. 2005;42:83-88 (Pubitemid 41134017)
7. Coelho JCU, de Freitas ACT, Matias JEF, Zeni-Neto C, de Godoy JL, Parolin MB, Okawa L. Donor complications including the report of one death in right-lobe living donor liver transplantation. Dig Surg. 2007;24:191-196 (Pubitemid 47000383)
8. Gaglio PJ, Malireddy S, Levitt BS, Lapointe-Rudow D, Lefkowitch J, Kinkhabwala M, Russo MW, Emond JC, Brown Jr RS. Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors. Liver Transpl. 2003;9:1028-1035 (Pubitemid 37304457)
9. Garcia-Retortillo M, Forns X, Llovet JM, Navasa M, Feliu A, Massaguer A, Bruguera M, Fuster J, Garcia-Valdecasas JC, Rimola A. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation. Hepatology. 2004;40:699-707. (Pubitemid 39265593)
10. Guo L, Orrego M, Rodriguez-Luna H, Balan V, Byrne T, Chopra K, Douglas DD, Harrison E, Moss A, Reddy KS, Williams JW, Rakela J, Mulligan D, Vargas HE. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients. Liver Transpl. 2006;12:560-565
11. Humar A, Horn K, Kalis A, Glessing B, Payne WD, Lake J. Living donor and splitliver transplants in hepatitis C recipients: does liver regeneration increase the risk for recurrence. Am J Transpl 2005;5:399-405. (Pubitemid 40179528)
12. Ichikawa T, Nakao K, Hamasaki K, Honda T, Shibata H, Akahoshi M, Eguchi S, Takatsuki M, Kanematsu T, Eguchi K. Clearance of hepatitis C virus after living-donor liver transplantation in spite of residual viremia on end date of interferon therapy before transplantation. World J Gastroenterol. 2007;13:4149-4151 (Pubitemid 47323175)
13. Kam I. Adult-adult right hepatic lobe living donor liver transplantation for status 2a patients: too little, too late. Liver Transpl. 2002;8:347-349 (Pubitemid 34467368)
14. Neto JS, Carone E, Pugliese V, Salzedas A, Fonseca EA, Teng H, Porta G, Pugliese R, Miura I, Baggio V, Hayashi M, Beloto M, Guimaraes T, Godoy A, Kondo M, Chapchap P. Living donor liver transplantation for children in Brazil weighing less than 10 kilograms. Liver Transpl. 2007;13:1153-1158 (Pubitemid 47305034)
15. Ono-Nita SK, Nita ME, Carrilho FJ. Hepatite C. Fatos em números. Arq Gastroenterol. 2006;43:71-72
16. Patel S, Orloff M, Tsoulfas G, Kashyap R, Jain A, Bozorgzadeh A, Abt P. Living-donor liver transplantation in the United States: identifying donors at risk for perioperative complications. Am J Transplant. 2007;7:2344-2349 (Pubitemid 47347861)
17. Rodrigues-Luna H, Vargas HE, Sharma P, Ortiz J, de Petris G, Balan V, Byrne T, Moss A, Mulligan D, Rakela J, Douglas DD. Hepatitis C virus recurrence in living donor liver transplant recipients. Dig Dis Sci. 2004;49:38-41. (Pubitemid 38183742)
18. Russo MW, Galanko J, Beavers K, Fried MW, Shrestha R. Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States. Liver Transpl. 2004;10:340-346 (Pubitemid 38380305)
19. Samuel D, Forns X, Berenguer M, Trautwein C, Burroughs A, Rizzetto M, Trepo C. Report of the Monothematic EASL Conference on Liver Transplantation (Paris, France, January 12-14, 2006). J Hepatol. 2006;45:127-143 (Pubitemid 43850627)
20. Samuel D, Roche B. Ribavirin in the treatment of recurrent hepatitis C after liver transplantation: difficult to manage but essential for success. J Hepatol. 2007;46:988-991 (Pubitemid 46671607)
21. Schiano TD, Gutierrez JA, Walewski JL, Fiel MI, Cheng B, Bodenheimer Jr H, Thung SN, Chung RT, Schwartz ME, Bodian C, Branch AD. Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver graft from living versus deceased donors. Hepatology. 2005;42:1420-1428 (Pubitemid 43260046)
22. Shifman ML, Stravitz RT, Contos MJ, Mills AS, Sterling RK, Luketic VA, Sanyal AJ, Cotterell D, Maluf D, Posner MP, Fisher RA. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation. Liver Transpl. 2004;10:1248-1255 (Pubitemid 39406078)
23. Shiffman ML. Treating chronic hepatitis C virus after liver transplantation: balancing the risks against the chance for success. Liver Transpl. 2007;13:1088-1091 (Pubitemid 47305026)
24. Stanca CM, Fiel MI, Kontorinis N, Agarwal K, Emre S, Schiano TD. Chronic ductopenic rejection in patients with recurrent hepatitis C virus treated with pegylated interferon alfa-2a and ribavirin. Transplantation. 2007;84:180-186 (Pubitemid 47205751)
25. Takada Y, Haga H, Ito T, Nabeshima M, Ogawa K, Kasahara M, Oike F, Ueda M, Egawa H, Tanaka K. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients. Transplantation. 2006;81:350-354 (Pubitemid 43255718)
26. Trotter JF, Wisniewski KA, Terrault NA, Everhart JE, Kinkhabwala M, Weinrieb RM, Fair JH, Fisher RA, Koffron AJ, Saab S, Merion RM, A2ALL Study Group. Outcomes of donor evaluation in adult-to-adult living donor liver transplantation. Hepatology. 2007;46:1476-1484
27. Trotter J, Schiano T, Kim-Schluger L. Living donor liver transplantation in hepatitis C patients short-term results compared to cadaveric transplantation. Am J Transpl. 2001;1(suppl):316A.
28. Van Vlierberche, Troisi R, Colle I, Ricciardi S, Praet M, de Hemptinne B. Hepatitis C infection-related liver disease: patterns of recurrence and outcome in cadaveric and living-donor liver transplantation in adults. Transplantation. 2004;77:210-214 (Pubitemid 38155748)
29. Wiesner RH, Sorrell M, Villamil F, International Liver Transplantation Society Expert Panel. Report of the first international Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C. Liver Transpl. 2003;9(suppl 3):S1-9. (Pubitemid 37407996)